Nexvel Biotech, a specialized company in aesthetic medicine and cosmeceuticals, will make its first appearance at Cosmobeauté Vietnam 2026, signaling the company's official entry into the Southeast Asian market.

This exhibition represents a significant milestone in Nexvel Biotech's global expansion strategy, serving as the first official platform to introduce its proprietary hyaluronic acid (HA)-based technologies and medical aesthetic expertise to Southeast Asia.

At the exhibition, Nexvel Biotech will showcase its flagship skin booster and cosmeceutical product portfolio developed through years of research and innovation. The company aims to establish new business opportunities with buyers, distributors, and industry professionals across the rapidly growing Southeast Asian beauty market.

Demand for scientifically proven, technology-driven cosmeceutical solutions continues to rise throughout Southeast Asia, as consumers increasingly seek products that deliver measurable results beyond conventional skincare benefits. Leveraging its extensive expertise in HA research and proprietary technology platforms, Nexvel Biotech is well-positioned to demonstrate its competitive strengths to international partners.

A company representative stated, "Cosmobeauté Vietnam 2026 is a meaningful opportunity for Nexvel Biotech to take its first step into the Southeast Asian market. Through this exhibition, we aim to build strategic partnerships, expand our global network, and strengthen our position as a leading provider of aesthetic and cosmeceutical solutions."

The exhibition is expected to serve as a launchpad for Nexvel Biotech's Southeast Asian growth strategy and a key milestone in bringing its innovative technologies to new international markets.